stella
beta
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study — Stella
Recruiting
Back to Prostate Adenocarcinoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
View full record on ClinicalTrials.gov